Wiley says it's also the first time the group has become EBITDA positive, generating $4.6M in EBITDA and cash of $6.2M.
Amryt Pharma generates 'significant' top line and bottom line metrics in 1Q of this year
Quick facts: Amryt Pharma PLC
Price: 207 GBX
Market Cap: £336.85 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Amryt Pharma PLC named herein, including the promotion by the Company of Amryt Pharma PLC in any Content on the Site, the Company receives from...FOR OUR FULL DISCLAIMER CLICK HERE